Stockholm, January 7, 2020 – Swedish digital health company Coala Life today announced a research and development partnership with Asahi Kasei Corporation in Japan. The collaboration includes a development program and feasibility research targeting Heart Failure (HF) patients in Japan. Nearly one million patients are suffering from Heart Failure (HF) in Japan. The country also has the …
IRVINE, December 19, 2019 – The High Desert Heart Institute in California, part of nationwide Prime Healthcare group, has signed a partnership with Coala Life to utilize the Coala Heart Monitor on a broad scale. The agreement constitutes the first major healthcare provider contract for Coala Life in the US following recent market launch. Clinical …
STOCKHOLM, DECEMBER 11, 2019 – In order to continue our strategic drive to grow the health care business and align our sales and marketing efforts the role Chief Commercial Officer has been created. With the recent FDA clearance for Coala in the US and the subsequent launch in the US, Germany and soon the Netherlands, …
STOCKHOLM, November 22, 2019 – Implementation of the Coala Heart Monitor leads to higher clinical efficiency, lower costs, shorter waiting lists and higher patient satisfaction. That is the results of a clinical evaluation performed at the Cardiology Clinic at Aleris Sabbatsberg. In 2019, Aleris Cardiology Clinic at Sabbatsberg hospital used Coala Heart Monitor to …
St. Louis Cardiology Center clinic was first in the U.S. to use the Coala Heart Monitor for the remote monitoring of patients with suspected AF. Jerome Dwyer M.D. M.B.A. commented; “The real-time Coala monitor reduces patient cost, contributes to lowering U.S. healthcare spending, while at the same time improving diagnostic accuracy for my patients. Plus …
“Swedish medical device startup expands into St. Louis A Swedish medical device startup has expanded into St. Louis, with the possibility that it could locate its U.S. headquarters here.” Read full article here.
Coala Life is proud to announce the formation of the new US clinical advisory board. First meeting held at the new BioSTL headquarters in St Louis. Jerome V. Dwyer, MD, MBA, Cardiologist and Electrophysiologist, St. Louis Cardiology Center. Dr. Dwyer is a serial entrepreneur, investor, fundraiser, advisor, and physician whose passion is creating and growing …
Irvine, CA, US – October 2nd, 2019 – Swedish digital health company Coala Life today announced its market launch in the US in collaboration with leading US cardiologists and healthcare providers. The launch follows recent FDA clearance for the Coala Heart Monitor and subsequent A-series funding. The Coala Heart Monitor (“Coala”) is a real-time …
STOCKHOLM August 30, 2019 – Today Coala Life announces entry into the Dutch market in partnership with Luscii. The Netherlands, with healthcare expenditures approaching $100 Bn, is a major and influential hub in the European medical device industry frequently ranked in the top 5 global medical device markets. The Swedish medtech company Coala Life, …
